| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.80B | 5.15B | 4.33B | 5.71B | 4.90B | 4.63B |
| Gross Profit | 2.50B | 2.23B | -720.70M | -975.08M | -1.13B | 1.80B |
| EBITDA | 655.11M | 434.25M | -207.22M | 722.57M | 1.14B | 624.07M |
| Net Income | 280.27M | 136.75M | -310.67M | 409.34M | 700.37M | 421.09M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 6.34B | 6.26B | 5.34B | 4.43B | 3.11B |
| Cash, Cash Equivalents and Short-Term Investments | 36.69M | 36.69M | 73.65M | 62.42M | 17.57M | 8.72M |
| Total Debt | 0.00 | 1.26B | 1.49B | 1.18B | 588.47M | 54.98M |
| Total Liabilities | -3.71B | 2.63B | 2.73B | 2.25B | 1.73B | 1.07B |
| Stockholders Equity | 3.71B | 3.71B | 3.53B | 3.09B | 2.70B | 2.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 324.44M | -131.67M | -464.73M | -429.47M | 254.41M |
| Operating Cash Flow | 0.00 | 399.05M | -51.04M | -362.60M | -85.82M | 444.56M |
| Investing Cash Flow | 0.00 | -41.33M | -115.35M | -81.45M | -316.63M | -212.70M |
| Financing Cash Flow | 0.00 | -358.86M | 164.22M | 447.50M | 402.07M | -233.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹6.91B | 16.40 | ― | 0.36% | 22.68% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹866.92M | 9.02 | ― | 2.37% | 44.31% | ― | |
57 Neutral | ₹9.98B | 15.57 | ― | ― | 67.43% | ― | |
55 Neutral | ₹3.20B | 29.62 | ― | ― | 25.88% | -44.00% | |
45 Neutral | ₹3.37B | -4.50 | ― | ― | 10.07% | -35.05% | |
40 Underperform | ₹2.96B | -8.56 | ― | ― | -99.98% | -101.75% |
Rama Phosphates Limited has released its financial performance presentation for the quarter ended September 30, 2025. This announcement provides stakeholders with insights into the company’s financial health and operational progress, potentially impacting its market positioning and investor confidence.